MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202527124119 A) filed by Shanghai Henlius Biotech, Inc.; and Shanghai Henlius Biologics Co. , Ltd. on December 09, 2025, for Anti-Pdl1 Antibody-Drug Conjugate And Use.
Inventors include Shan, Yongqiang; Song, Hongbin; Song, Ge; Jiang, Jiahao; and Zhang, Wentao.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: An antibody-drug conjugate (ADC) and a use thereof. The present invention relates to a novel anti-PDL1 ADC and a method and use thereof for treating diseases or conditions related to PDL1 expression.
Disclaimer: Curated by HT Syndication....